CRS Clinical Research Services Management GmbH — Clinical Trial Site

53 Registered trials

2 Currently recruiting

Organisation

CRS Clinical Research Services Management GmbH

Location

Mannheim, Germany

Identifier

ORG-100039537

Address

Siemensdamm 65, Siemensstadt, 13627, Germany

Departments

Abteilung Klinische Studien Phase I/II
Clinic
Clinical Investigator
Clinical Pharmacology Unit
Clinical Pharmacology Unit, Board of Managing Directors
Clinical Unit
CRS Clinical Research Services Berlin GmbH
CRS Clinical Research Services Management GmbH
CRS Clinical Research Services Mannheim GmbH
Dermatology
Mannheim
Mannheim GmbH
Medical & Managing Director
Medical Director
N/A
NA
Not applicable
Phase I Unit

Clinical trials at this site (53)

Search interface

An Open-label, Single-dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of JNJ-77242113 in Adult Participants Ended

2023-510161-97-00 Renal Impairment 3 2024-06-19
A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body Ended

2023-509951-15-00 Pharmacokinetic trial 2 2024-06-06
A study in healthy people to test how BI 1015550 is taken up in the body when given with or without food Ended

2023-509889-38-00 Healthy volunteer trial 3 2024-05-28
A study to test how BI 456906 is taken up in the blood of people with and without kidney problems Ended

2023-508557-13-00 Renal impairment (mild, moderate and severe) 3 2024-05-08
A study in healthy people to see how zongertinib is taken up into the blood when given as tablets made by two different manufacturers Ended

2023-510495-31-00 Healthy volunteer trial 2 2024-04-24
A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control W… Ended

2023-507206-13-00 Type 2 Diabetes 5 2024-03-14
A study to learn if baxdrostat works at reducing blood pressure and is safe in people with high blood pressure Ended

2023-505499-32-00 Uncontrolled hypertension (uTHN) defined as blood press 5 2024-03-08
A six-way relative bioavailability study comparing 10, 30, 40 and 50 mg leniolisib film coated tablets and 30 mg film coated granules with 7… Ended

2023-508880-61-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 3 2024-03-06
A study to test whether multiple doses of BI 456906 have an effect on cardiac safety in people with overweight or obesity. Ended

2023-506375-10-00 Healthy volunteer trial 3 2024-03-04
An open-label, single-dose, parallel-group study to evaluate the plasma pharmacokinetics of leniolisib in subjects with impaired hepatic fun… Ended

2023-508519-22-00 Activated Phosphoinositide 3-Kinase Delta Syndrome 3 2024-01-26
A study in healthy people to test whether iclepertin has an effect on cardiac safety Ended

2023-504693-38-00 Healthy 3 2024-01-25
This is a clinical trial (study), to be conducted in several clinical sites worldwide, of an oral study drug which will be investigated in a… Ended

2023-503957-36-00 Moderate-to-Severe pruritus in adult subjects with nota 10 2023-12-04
A study in healthy men to test how BI 1810631 is taken up in the body when taken with or without food Ended

2022-502860-19-00 Healthy volunteer trial 3 2023-10-19
A Phase I study to evaluate the pharmacokinetics, safety, and tolerability of multiple oral doses of obefazimod in patients with mild and mo… Ended

2023-505299-31-00 Ulcerative colitis and rheumatoid a1thritis 3 2023-10-09
A study to learn about how much elinzanetant gets absorbed in the blood and how safe it is in healthy participants when taken as different t… Ended

2023-503968-16-00 Vasomotor symptoms as a sex hormone-dependent disorder 3 2023-09-25
A double-blind, randomized, placebo-controlled, dose-escalating Phase I trial to determine the safety, pharmacokinetic parameters, and clini… Ended

2023-504671-24-00 Men and women infertility 1 2023-09-22
A study in healthy men to test whether carbamazepine influences the amount of BI 1810631 in the blood Ended

2022-503046-50-00 Healthy volunteer trial 3 2023-09-11
A study in healthy women to test whether BI 1358894 influences the amount of a contraceptive in the blood Ended

2022-502861-78-00 Pharmacokinetic trial 3 2023-09-08
A study to compare how different medicines (rosuvastatin, digoxin, metformin, and furosemide) are handled by the body of healthy people and … Ended

2024-514621-29-00 1. Patients with compensated liver cirrhosis due to any 3 2023-09-07
A Phase I (First-in-Human) Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and… Ended

2023-504450-35-00 Plaque psoriasis 1 2023-08-21
A study to test how kidney problems influence the blood concentrations of efgartigimod Ended

2023-503992-88-00 renal impairment 3 2023-07-14
A study to compare how much of the study treatment finerenone gets into the blood when the same amount is taken in one and in two tablets in… Ended

2022-502385-24-00 Heart failure with left ventricular ejection fraction ≥ 2 2023-04-27
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon) Ended

2022-501538-44-00 Atopic Dermatitis 5 2023-04-25
A study to compare how different substances (caffeine, warfarin, omeprazole, metoprolol, and midazolam) are handled by the body of healthy p… Ended

2024-514622-22-00 1. Patients with compensated liver cirrhosis due to any 3 2023-04-25